Halobetasol propionate-d3

CAS : 66852-54-8

Ref. 3D-FH57683

Informations sur le produit

• Nom: Halobetasol propionate-d3
• Synonymes: (6α,11β,16β)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione, Bmy 30056, Cgp 14458, Halobetasol propionate, Miracorten, Ulobetasol propionate, Ultravate, ethyl (6alpha,11beta,16beta)-21-chloro-6,9-difluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17-carboxylate, (6alpha,8xi,10xi,13xi,14xi,16beta)-21-chloro-6,9-difluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate, 21-Chloro-6alpha,9-difluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate, (6alpha,11beta,16beta)-21-chloro-6,9-difluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate, Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (6α,11β,16β)-

Description

Halobetasol propionate-d3 is a biocompatible polymer that binds to the effector proteins of the inflammatory response. It is used in the treatment of inflammatory bowel disease, psoriasis, and other skin diseases. Halobetasol propionate-d3 has been shown to be effective against plaque and cutaneous lesions in patients with psoriasis. This drug also inhibits the production of proinflammatory cytokines (IL-1β, IL-6, IL-8) and chemokines (MCP-1) by monocytes. The drug has been shown to be effective against autoimmune diseases due to its ability to inhibit TNFα production from macrophages. Halobetasol propionate-d3 is compatible with blood group A, B, and AB.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 484.96 g/mol
• Formule: C₂₅H₃₁ClF₂O₅
• Degré de pureté: Min. 95%